Semaglutide online access for Reading, Pennsylvania
Company statements checked between September 10, 2026 and September 23, 2026: 3 covered companies — Gentle Health, GoodRx Care and Mochi Health — advertise online access to Semaglutide for patients in Pennsylvania, including Reading. Confirm eligibility and total charges with the provider.
Browse online Semaglutide programs advertised for patients in Reading, Pennsylvania, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded oral semaglutide · Compounded injectable semaglutide | $112/mo advertised monthly bundle, Compounded oral semaglutide | Official site ↗ | |
| GoodRx Care | Wegovy pen · Wegovy HD · Wegovy tablet | $188/mo partial monthly subtotal, Wegovy tablet | Official site ↗ | |
| Mochi Health | Compounded semaglutide | $139/mo partial monthly subtotal, Compounded semaglutide | Official site ↗ |
Health context in Reading
Semaglutide programs are marketed for weight management and, for some products, type 2 diabetes. These Reading figures give local context only. Among the 5 Pennsylvania cities in this research set, Reading has the highest estimate for obesity among adults (43.3%), the highest estimate for diagnosed diabetes among adults (16.2%), the highest estimate for high blood pressure among adults (34.9%) and the highest estimate for lack of health insurance among adults aged 18–64 (24.8%).
| Measure | Reading | 95% range | Among the 5 Pennsylvania cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 43.3% | 35.8–51.1% | highest | 2022 |
| Diagnosed diabetes among adults | 16.2% | 14.1–18.4% | highest | 2022 |
| High blood pressure among adults | 34.9% | 31–38.9% | highest | 2021 |
| Lack of health insurance among adults aged 18–64 | 24.8% | 22.3–27.3% | highest | 2022 |
| Routine checkup in the past year among adults | 77.2% | 73.2–80.9% | fourth-highest | 2022 |
Source: CDC PLACES, 2024 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 95,112); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This semaglutide page is the Reading entry point to the Pennsylvania statewide online listing, not evidence of an office, pharmacy or clinician in Reading. Each company below appears because its named products have their own Pennsylvania evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the Pennsylvania guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in Pennsylvania, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Reading, and a listing is not a prescription, appointment or coverage guarantee. Read the Pennsylvania Semaglutide guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's compounded oral and injectable semaglutide programs, if prescribed, billed through its medication-order subscription.
Compounded oral semaglutide (oral): 2–4 mg/day — $112/mo · >4–8 mg/day — $189/mo · >8–12 mg/day — $258/mo
Compounded injectable semaglutide (injection): 0.24–0.48 mg/week — $135/mo · >0.48–1.2 mg/week — $159/mo · >1.2–2.4 mg/week — $199/mo
- Compounded oral semaglutide — oral: state evidence checked · Availability source · Full evidence notes
- Compounded injectable semaglutide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
GoodRx Care
GoodRx Care Direct's separately priced branded semaglutide offers, billed apart from its monthly membership fee.
Wegovy pen (pen): 0.25 and 0.5 mg, first two fills — $238/mo · after the first two fills — $388/mo
Wegovy HD (pen): 7.2 mg — $438/mo
Wegovy tablet (oral tablet): 1.5 mg — $188/mo · 4 mg — $238/mo · higher doses, from — $338/mo
- Wegovy pen — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy HD — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy tablet — oral tablet: state evidence checked · Availability source · Full evidence notes
Mochi Health
Mochi's paid membership route with separately billed compounded semaglutide injections, if prescribed.
Compounded semaglutide (injection): 0.22 mg/week — $139/mo · 0.44 mg/week — $149/mo · 0.88 mg/week — $161/mo · 1.5 mg/week — $171/mo · 2.21 mg/week — $175/mo · 2.67 mg/week — $178/mo
- Compounded semaglutide — injection: state evidence checked · Availability source · Full evidence notes
Health center sites with Reading addresses
If you want an in-person visit, HRSA-listed health center sites with Reading postal addresses include:
- Berks Community Health Center (Berks Community Health Center) — 838 Penn St, Reading, PA 19602 · 610-988-4838
From the HRSA health center directory (data retrieved ), listed alphabetically by organization and matched by postal address, not city boundaries; the list includes health center look-alikes, which do not receive Health Center Program funding. Not a ranking or recommendation. Call to confirm services, costs and whether a site can help with the programs on this page.
More listings
Other medications for Reading: GLP-1 medication access · Tirzepatide
Semaglutide in other Pennsylvania cities: Allentown · Erie · Philadelphia · Pittsburgh
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.